VSVikramjeet Singh

Vikramjeet Singh

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Vikramjeet Singh has a total of 10 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A prospective study on the evaluation of a novel immunochromatographic card for the rapid detection of five carbapenemase enzymes in metallo-beta-lactamase producers

    by Jyotsna Agarwal, Vikramjeet Singh, Avneesh Sharma, Manodeep Sen, Anupam Das

    Objective. To evaluate the performance of a novel immunochromatographic (IC) card test (TRURAPID® O.K.N.V.I. RESIST-5) for rapid detection of five carbapenemase enzymes in metallo-beta-lactamase (MBL)-producing organisms, compared to real-time PCR and an Advanced Expert System (AES). Methods. Clinically isolated 100 non-duplicates of multidrug-resistant Gram-negative bacilli expressing MBL production were tested using the novel IC card, real-time PCR and the Vitek-2 AES. Sensitivity, specificity and turnaround time were evaluated. Results. The novel IC card showed high sensitivity for detecting NDM (93%) and KPC (91.7%) carbapenemases, but lower sensitivity for OXA-48 (60%), VIM (67%) and IMP (33%) compared to PCR. It had a rapid turnaround time of 15–20 min versus 5–7 h for PCR and 18–22 h for AES. Conclusion. The novel IC card offers a rapid, cost-effective approach for detecting carbapenemases, particularly NDM and KPC, in clinical microbiology practice. It may be beneficial in resource-limited settings where these enzymes are prevalent. Considering the limited sensitivity for the IMP and VIM genes, this warrants confirmatory testing by PCR. Further evaluation is needed to assess its role as a screening or confirmatory test, especially during nosocomial outbreaks.


  • Open Access

    A prospective study on evaluation of Novel Immunochromatographic card for rapid detection of Five carbapenemases enzymes in metallobetalactamase producers.

    by Jyotsna Agarwal, Vikramjeet Singh, Avneesh Sharma, Manodeep Sen, Anupam Das

    Objective To evaluate the performance of a novel immunochromatographic card test (TRURAPID® O.K.N.V.I. RESIST-5) for rapid detection of five carbapenemase enzymes in metallo-beta-lactamase (MBL) producing organisms, compared to real-time PCR and an advanced expert system. Methods Isolated clinically 100 non-duplicates of multidrug-resistant Gram-negative bacilli (GNB) expressing MBL production were tested using the novel IC card, real-time PCR, and the Vitek-2 Advanced Expert System (AES). Sensitivity, specificity, and turnaround time were evaluated. Results The novel IC card showed high sensitivity for detecting NDM (93%) and KPC (91.7%) carbapenemases, but lower sensitivity for OXA-48 (60%), VIM (67%), and IMP (33%) compared to PCR. It had a rapid turnaround time of 15-20 minutes versus 5-7 hours for PCR and 18-22 hours for AES. Conclusion The novel IC card offers a rapid, cost-effective approach for detecting carbapenemases, particularly NDM and KPC, in clinical microbiology practice. It may be beneficial in resource-limited settings where these enzymes are prevalent. Further evaluation is needed to assess its role as a screening or confirmatory test, especially during nosocomial outbreaks. Data Summary New tool is being evaluated against Polymerase chain reaction for early detection of carbapenemase gene. No code or software is generated. Impact Statement This article evaluates a novel immunochromatographic card test for rapid detection of five carbapenemase enzymes in metallo-beta-lactamase producing bacteria. The Novel IC test showed high sensitivity for NDM, OXA and KPC enzymes, which is pertinent in context to Indian subcontinent. It offers a rapid 15-20 minutes turnaround time versus hours for other methods, potentially beneficial in resource-limited settings in a fight against carbapenem resistance.

  • Open Access

    A prospective study on evaluation of Novel Immunochromatographic card for rapid detection of Five carbapenemases enzymes in metallobetalactamase producers.

    by Jyotsna Agarwal, Vikramjeet Singh, Avneesh Sharma, Manodeep Sen, Anupam Das

    Objective To evaluate the performance of a novel immunochromatographic card test (TRURAPID® O.K.N.V.I. RESIST-5) for rapid detection of five carbapenemase enzymes in metallo-beta-lactamase (MBL) producing organisms, compared to real-time PCR and an advanced expert system. Methods Isolated clinically 100 non-duplicates of multidrug-resistant Gram-negative bacilli (GNB) expressing MBL production were tested using the novel IC card, real-time PCR, and the Vitek-2 Advanced Expert System (AES). Sensitivity, specificity, and turnaround time were evaluated. Results The novel IC card showed high sensitivity for detecting NDM (93%) and KPC (91.7%) carbapenemases, but lower sensitivity for OXA-48 (60%), VIM (67%), and IMP (33%) compared to PCR. It had a rapid turnaround time of 15-20 minutes versus 5-7 hours for PCR and 18-22 hours for AES. Conclusion The novel IC card offers a rapid, cost-effective approach for detecting carbapenemases, particularly NDM and KPC, in clinical microbiology practice. It may be beneficial in resource-limited settings where these enzymes are prevalent. Further evaluation is needed to assess its role as a screening or confirmatory test, especially during nosocomial outbreaks. Data Summary New tool is being evaluated against Polymerase chain reaction for early detection of carbapenemase gene. No code or software is generated. Impact Statement This article evaluates a novel immunochromatographic card test for rapid detection of five carbapenemase enzymes in metallo-beta-lactamase producing bacteria. The Novel IC test showed high sensitivity for NDM, OXA and KPC enzymes, which is pertinent in context to Indian subcontinent. It offers a rapid 15-20 minutes turnaround time versus hours for other methods, potentially beneficial in resource-limited settings in a fight against carbapenem resistance.

  • Open Access

    Inconsistencies in the Indian Guidelines for the Prescription of Antibiotics for Critically Ill Patients

    by Soumya S Nath, Vikramjeet Singh, Nikhil Raj, Jyotsna Agarwal

    Raj N, Nath SS, Singh V, Agarwal J. Inconsistencies in the Indian Guidelines for the Prescription of Antibiotics for Critically Ill Patients. Indian J Crit Care Med 2024;28(10):908–911.


  • Open Access

    Healthcare-associated Diarrhea due to Clostridioides difficile in Patients Attending a Tertiary Care Teaching Hospital of North India

    by Manodeep Sen, Anupam Das, Vikramjeet Singh, Nikhil Raj, Jyotsna Agarwal

    Healthcare-associated diarrhea (HCAD) is diarrhea that develops at least after 3 days of hospitalization, with the most common infectious cause being Clostridioides difficile. Over the last decade, there has been a remarkable growth in the frequency and severity of C. difficile infection (CDI), making it one of the most prevalent healthcare-associated infections. This study aimed to analyze the prevalence and risk factors associated with CDI. A total of 107 patients with clinical suspicion of having HCAD were included in this study. Enzyme-linked fluorescent assay (ELFA) technique-based glutamate dehydrogenase (GDH) and toxin A/B assay were used as per the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) for diagnosing CDI. The details about associated comorbidities were retrieved from the hospital information system records. The presence of risk factors was noted. Risk factors associated with CDI were looked for. Out of the 107 stool samples received in the microbiology laboratory from patients with suspected HCAD eight (7.6%) samples were positive for CDI. The most frequent comorbidity observed in these patients was renal illness (acute or chronic kidney disease). In this study, a total of 7/8 cases were on multiple antibiotics most common being carbapenem. The 6-year prevalence of CDI observed in this study was found to be 7.6% risk factors, associated with CDI were kidney disease, diabetes mellitus, malignancy, and exposure to broad-spectrum antibiotics. Raj N, Agarwal J, Singh V, et al. Healthcare-associated Diarrhea due to Clostridioides difficile in Patients Attending a Tertiary Care Teaching Hospital of North India. Euroasian J Hepato-Gastroenterol 2024;14(1):60–64.


  • Open Access

    Evaluation of Direct Antimicrobial Susceptibility Testing from Positive Flagged Blood Cultures in Sepsis Patients

    by Soumya S Nath, Vikramjeet Singh, Jyotsna Agarwal, Avneesh Sharma

    Presently, many laboratories are equipped with automated system for antimicrobial susceptibility testing (AST) for minimum inhibitory concentration-based reporting which enables the clinician to choose the right antimicrobial for timely treatment of sepsis. The study aimed to assess performance of direct AST from blood culture positive broth using automated AST system for accuracy and time taken to release the report. The present study conducted in a 25-bedded ICU in North India for 12 months. Single morphotype of bacteria on gram stain from positively flagged blood culture bottles were included, which was directly identified (using an in-house protocol) with MALDI-TOF-MS from positive blood culture broths. DAST was carried out from 200 such blood culture broths and results were compared with reference AST (RAST) which was also done using VITEK-2 using overnight grown bacterial colonies as per standard protocol. Among 60 isolates of Enterobacterales, 99% categorical agreement for both E. coli and K. pneumoniae observed by two methods were tested for AST. Among non-fermenters, Pseudomonas aeruginosa showed a categorical agreement of 99.6%, as compared with Acinetobacter spp. and exotic GNBs, which showed 95–96% agreement. A significant difference of 18–24 hours was noted in time to release the report between DAST and RAST, for GNB and GPC both. Direct AST from positive flagged blood culture bottles can significantly reduce the time to release the bacterial susceptibility report by up to 24 hours, at the same time maintaining the accuracy. Singh V, Agarwal J, Nath SS, Sharma A. Evaluation of Direct Antimicrobial Susceptibility Testing from Positive Flagged Blood Cultures in Sepsis Patients. Indian J Crit Care Med 2024;28(4):387–392.


  • Open Access

    Reversing the Trend of Antimicrobial Resistance in ICU: Role of Antimicrobial and Diagnostic Stewardship

    by Rajeev Kumar, Manodeep Sen, Anupam Das, Jyotsna Agarwal, Soumya S Nath, Vikramjeet Singh

    Increasing antimicrobial resistance (AMR) among common bacteria combined with the slow development of new antibiotics has posed a challenge to clinicians. To demonstrate whether antimicrobial and diagnostic stewardship program (ASP and DSP)-related interventions improve antibiotic susceptibilities among common bacteria causing bloodstream infections (BSI) in patients admitted to the intensive care unit (ICU) and whether these resulted in changes in the volume of antimicrobial consumption. We compared the susceptibility patterns of gram-negative bacteria (GNB) and gram-positive cocci (GPC) causing BSI and changes in the volume of antibiotics prescribed for the same before and after 2017 by a retrospective analysis. Postintervention, there was increased susceptibility of all GNBs to aminoglycosides; Escherichia coli and Klebsiella spp. to beta-lactambeta-lactamase inhibitors (BLBLI) combinations; and Klebsiella spp. and Pseudomonas spp. to carbapenems. Acinetobacter spp., Klebsiella spp., and Pseudomonas spp. showed improved susceptibility to doxycycline, whereas E. coli and Klebsiella spp. showed significantly improved susceptibility to fluoroquinolones. Among GPCs, there was increased susceptibility of Staphylococcus aureus (levofloxacin, clindamycin, and aminoglycoside), coagulase-negative S. aureus (CoNS) (chloramphenicol, levofloxacin, clindamycin, and aminoglycoside), and enterococci (chloramphenicol, levofloxacin, and clindamycin). There was a significant reduction in usage of antimicrobials for the treatment of GPCs (linezolid, doxycycline, chloramphenicol, levofloxacin, BLBLI, macrolide, and cephalosporin) and GNBs (levofloxacin, cephalosporin, carbapenem, and colistin), which caused BSI. The present study illustrated that combined ASP and DSP interventions successfully reversed the resistance pattern of organisms causing BSI and resulted in a reduction in antibiotic utilization. Agarwal J, Singh V, Das A, Nath SS, Kumar R, Sen M. Reversing the Trend of Antimicrobial Resistance in ICU: Role of Antimicrobial and Diagnostic Stewardship. Indian J Crit Care Med 2021;25(6):635–641.